FATE - Fate Therapeutics GAAP EPS of -$0.47 in-line revenue of $1.93M beats by $0.67M
2024-05-09 16:04:34 ET
More on Fate Therapeutics
- Fate Therapeutics: As Its Rally Fizzles, We May Be Near The Bottom
- Fate Therapeutics: Looking For A Potential Turnaround In 2024
- Fate Therapeutics, Inc. (FATE) Q4 2023 Earnings Call Transcript
- Fate Therapeutics Q1 2024 Earnings Preview
- Fate Therapeutics announces pricing of $100M underwritten offering and concurrent private placement